NivolumabInterstitial lung disease: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1712卷 / 1期

关键词：

D O I：

10.1007/s40278-018-49687-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：398 / 398

相关论文

共 50 条

[41] ImatinibInterstitial lung disease: case report
Reactions Weekly, 2015, 1564 (1) : 104 - 104
[42] OsimertinibInterstitial lung disease: case report
Reactions Weekly, 2022, 1908 (1) : 452 - 452
[43] LenalidomideInterstitial lung disease: case report
Reactions Weekly, 2017, 1667 (1) : 193 - 193
[44] AlectinibInterstitial lung disease: case report
Reactions Weekly, 2017, 1655 (1) : 16 - 16
[45] OsimertinibInterstitial lung disease: case report
Reactions Weekly, 2018, 1700 (1) : 200 - 200
[46] CetuximabInterstitial lung disease: case report
Reactions Weekly, 2017, 1651 (1) : 75 - 75
[47] IxekizumabInterstitial lung disease: case report
Reactions Weekly, 2024, 2039 (1) : 285 - 285
[48] GefitinibInterstitial lung disease: case report
Reactions Weekly, 2013, 1450 (1) : 18 - 18
[49] RituximabInterstitial lung disease: case report
Reactions Weekly, 2016, 1617 (1) : 196 - 196
[50] CrizotinibInterstitial lung disease: case report
Reactions Weekly, 2016, 1597 (1) : 70 - 70

← 1 2 3 4 5 →